Profile for Serbia Patent: 65324
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Serbia Patent: 65324
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Get Started Free | Oct 17, 2034 | Novartis | PLUVICTO | lutetium lu-177 vipivotide tetraxetan |
| ⤷ Get Started Free | Nov 12, 2035 | Novartis | PLUVICTO | lutetium lu-177 vipivotide tetraxetan |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
